August 15, 2025
Request for Comments: Newborn Screening, Comment by September 15
The Health Resources and Services Administration (HRSA) is considering recommending the Secretary of Health and Human Services add Metachromatic Leukodystrophy (MLD) and Duchenne Muscular Dystrophy (DMD) to the Recommended Uniform Screening Panel (RUSP).
HRSA is providing notice and requesting comments from the public on these potential recommendations. The notices can be found here:
HRSA is particularly interested in comments that address the potential benefit of early screening for these conditions within the newborn period, the ability of state newborn screening programs to screen for them, and the availability of effective treatments.
Submit comments by September 15, 2025
See evidence reviews for MLD and DMD for additional information: